Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, ...
The image shows how the algorithm processes the typically coloured tissue section (left) and creates a map in which different types of tissue can be seen in different colours (the algorithm identifies ...
At AACR 2026, researchers presented Path-IO, an AI-driven pathomics model that predicts which metastatic non-small cell lung cancer patients will benefit from immunotherapy. Validated across global ...
New drugs have made America’s deadliest cancer more treatable than ever. So why aren’t they reaching patients?
In a recent study published in the journal Nature, researchers developed and evaluated the Providence Gigapixel Pathology Model (Prov-GigaPath), a whole-slide pathology foundation model, to achieve ...
SAN ANTONIO, May 08, 2026--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need ...
Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit sales for its CyPath® Lung ...
Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results